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Background: Exposure to organochlorine compounds (OCs) has been a subject of interest in recent years,
given their potential neurotoxicity. Meconium is easily available and accumulates neurotoxicants and/or
metabolites from the 12th week of gestation.
Aims: To determine whether neurotoxicants, specifically OCs, could be detected in serially collected
meconium, and to compare the results with those obtained in cord blood samples.
Methods: A sample of cord blood and three serial stool samples were analysed in 10 newborns.
Pentachlorobenzene (PeCB), hexachlorobenzene (HCB), polychlorinated biphenyls (PCBs), dichlorodiphe-
nyl trichloroethane (p,p9-DDT) and its metabolite dichlorodiphenyl dichloroethylene (p,p9-DDE), and
hexachlorocyclohexane isomers (a-, b-, c-, and d-HCH) were analysed by gas chromatography.
Results: From serial stool collection and analysis in newborns, there was an increase in the concentrations
of HCB, p,p9-DDE, PCBs, and b-HCH between the first and last stools of the newborn. Levels of DDT
diminished as pregnancy progressed. Concentrations in cord blood were positively associated with
concentrations in meconium for p,p9-DDE and b-HCH.
Conclusions: Meconium is a very useful instrument for the investigation of fetal exposure to neurotoxicants;
serial collection and analysis of meconium should estimate the timing and degree of in utero exposure of
the fetus to neurotoxicants. Analysis and interpretation of neurotoxicants in meconium results is a complex
process. Measurement in meconium of a wide range of neurotoxic substances should facilitate early
identification of harmful exposures, and enable rehabilitation and instigation of preventive measures.
E
xposure to organochlorine compounds (OCs) has been a
subject of interest in recent years given their potential
toxicity (carcinogenicity, inmunotoxicity, reproductive
system illnesses, and neurotoxicity).1 Contrary to what
happens in adults, exposure to neurotoxicants during the
windows of vulnerability in critical periods of brain develop-
ment can produce permanent cerebral dysfunction from
infancy, or it can delay its effect until adulthood.2 3
The ubiquity of neurotoxicants in the environment requires
development of methods of measuring the scope of exposure.
A useful approach consists of analysing biological samples
that accumulate the neurotoxicants or their metabolites
during the fetal period.4
Meconium, in addition to its diagnostic utility in certain
paediatric pathologies (cystic fibrosis, meconium ileus, ileal
stenosis or atresia, colon atresia, Hirschprung’s disease), is
very useful for investigation of fetal exposure to neurotox-
icants during pregnancy. Meconium has multiple advan-
tages: it is a discarded sample; there is a large amount of
available material; it begins to accumulate from the 12th
week of pregnancy (it may provide an indication of exposure
timing); and it is easily obtained.5
Meconium constitutes the first stools of the newborn.
Around 70% of full term newborns begin its expulsion within
the first 12 hours of life; 93% within the first 24 hours; and
99.8% during the first 48 hours.6 Some children in stress
situations expel meconium into the amniotic liquid before
being born, but even in those cases, the greatest amount of
meconium remains in the intestine. Meconium has a viscous
green-blackish aspect; it is very sticky. It is composed of
water, lipids, proteins, esterols and precursors of cholesterol,
products derived from swallowing the amniotic liquid
(including free fatty acids), epithelial cells, bile acids/salts,
and intestinal secretions.7 8 It starts to accumulate from the
13th week of pregnancy. Physiological fetal defecation of
small quantities of meconium occurs during the second three
month period, up to the 34th week of pregnancy.9
The objective of this exploratory study was to determine
whether neurotoxicants, specifically OCs, could be detected
in serially collected meconium, and to compare the results
with those obtained in cord blood samples. The present study
was carried out within the framework of a larger project
whose main objective is to measure the adverse effects of
exposure, not only to low, but also to simultaneous doses of
different neurotoxicants, and to study meconium as a
measure of the intrauterine exposure to multiple environ-
mental neurotoxicants.
MATERIALS AND METHODS
Between November and December 2004 we examined 10
mothers and their healthy full-term newborns in the
maternity unit of our hospital. Information on the parents
and newborns was obtained by means of a questionnaire.
Data concerning weight at birth, gestational age, and history
of meconium amniotic fluid were obtained from parental
record charts. Written consent was obtained from all parents.
This study has Institutional Review Board approval.
Cord blood and serial stool samples were collected and
tested for organochlorine levels from 10 newborn infants in
our maternity unit during the first 2–3 days of life before
discharge. Midwives were instructed to collect 5 ml of cord
blood using a glass syringe in the delivery room. Within
30 minutes blood samples were spun (4000 rpm) and
fractionated in different tubes. Parents were trained by the
Abbreviations: a-, b-, c-, d-HCH, hexachlorocyclohexane isomers;
HCB, hexachlorobenzene; OC, organochlorine compound; PCB,
polychlorinated biphenyl; PeCB, pentachlorobenzene; p,p9-DDE,
dichlorodiphenyl dichloroethylene; p,p9-DDT, dichlorodiphenyl
trichloroethane; TBB, tetrabromobenzene; TOC, total organic carbon
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paediatrician to collect meconium in the ward, using a metal
spatula and glass pots. Meconium obtained in the first
10 hours, between 11 and 20 hours, and afterwards until
48 hours of age were collected separately in three numbered
pots. All samples were frozen at 220 C˚. Sample storage did
not exceed 30 days. The metal spatula, glass pots, and tubes
were tested for possible contamination with OCs prior to
sample collection.
Materials
Standards of tetrabromobenzene (TBB), PeCB, HCB, a-, b-,
c-, and d-HCH, PCBs, 4,49-DDT, and 4,49-DDE were pur-
chased from Dr Ehrenstoffer (Augsburg, Germany).
Analytical grade concentrated sulphuric acid, acetonitrile,
iso-octane, and n-hexane were all purchased from Merck
(Darmstadt, Germany). Neutral aluminium oxide type 507C
was from Fluka AG (Switzerland).
Extraction
Cord blood (0.5 ml) and meconium (1–2 g) were introduced
into 10 ml centrifuge tubes and the recovery standards TBB
and PCB 209 were added. Concentrated sulphuric acid (2 ml)
and n-hexane (3 ml) were added and the mixture mixed on a
vortex mixer (ca. 1500 rpm, 30 seconds) and then centri-
fuged (ca. 1500 rpm, 10 minutes). The supernatant n-hexane
layer was aspirated into a second centrifuge tube using a
Pasteur pipette; a further 2 ml of n-hexane was added to the
first tube containing the sulphuric acid/serum or sulphuric
acid/meconium, the sample was mixed once more (vortex
mixer, ca. 1500 rpm, 30 seconds), and then centrifuged (ca.
Table 1 Limits of detection and quantification for cord blood and meconium samples
Compounds
Cord blood, limits (ng/ml) Meconium, limits (ng/ml)
Detection Quantification Detection Quantification
PeCB 0.018 0.024 0.018 0.027
HCB 2.53 3.87 0.373 0.490
b-HCH 0.07 0.11 0.065 0.12
PCB-28 0.064 0.088 0.117 0.143
PCB-52 0.516 0.789 0.147 0.187
PCB-101 0.069 0.083 0.166 0.239
4,49-DDE 0.026 0.036 0.219 0.332
PCB-118 0.018 0.029 0.043 0.057
PCB-153 0.052 0.078 0.081 0.116
4,49-DDT 0.026 0.039 0.032 0.047
PCB-138 0.028 0.035 0.114 0.159
PCB-180 0.047 0.076 0.025 0.034
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HCB β-HCH PCB28 PCB118 PCB153 PCB138 PCB180
0.0130 0.0044 0.0000 0.0003 0.0047 0.0019 0.0040
0.0190 0.0061 0.0006 0.0004 0.0103 0.0070 0.0066
0.0508 0.0136 0.0023 0.0024 0.0238 0.0161 0.0081
0.0000 0.0700 0.0000 0.0000 0.0100 0.0100 0.0000
Figure 1 Organochlorine
concentrations in serial meconium/TOC
(ng/ml) and cord blood serum samples
(data expressed as means).
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1500 rpm, 10 minutes). This last step was repeated, yielding
a combined extract of 7 ml of n-hexane, to which 2 ml
concentrated sulphuric acid was added, the sample mixed
(vortex mixer, ca. 1500 rpm, 90 seconds), centrifuged as
before, and the supernatant transferred to a conical,
bottomed, graduated tube. In the case of meconium samples
these extracts were cleaned up by adsorption chromatogra-
phy with glass columns (Pasteur pipettes, with 2 g of
aluminium oxide). The combined extracts were then reduced
to near dryness under a gentle stream of nitrogen and 10 ml
of an injection standard (PCB 142 in isooctane) was added.
The sample was quantitatively transferred to GC vials using
four 25 ml rinses of isooctane. If an emulsion was present at
any stage of the extraction, 10–15 drops of MilliQ water were
added before sample centrifugation.
Instrumental analysis
A gas chromatograph with electron capture detection
(Hewlett Packard 6890N GC-ECD) was used to quantify
PeCB and HCB, the ‘‘ICES 7’’ polychlorinated biphenyls
(PCBs 28, 52, 101, 118, 138, 153, 180), p,p9-DDT, and p,p9-
DDE, while a GC-MS (HP 5973 MSD) in negative chemical
ionisation mode (NCI) was used to quantify a-, b-, c-, and
d-HCH isomers. Samples were injected (2 ml) in splitless
mode onto a 60 m, ‘‘DB-5’’ column with a retention gap
(both from J&W/Agilent) in both instruments, with a flow of
1.5 ml/min helium for GC-ECD, and 1.0 ml/min ammonia for
GC-MS-NCI. The temperature programme in both instru-
ments was: 90 C˚, 2 minutes; 20 C˚/min to 140 C˚; 4 C˚/min to
200 C˚ held for 13 minutes; 4 C˚/min to 310 C˚ held for
10 minutes.
On both instruments, quantification was performed by
external standards (50, 25, 15, 12, 10, 7, 5, 3, 2, and 1 ng/ml),
using PCB 142 injection standard to correct for volume.
Recoveries of TBB and PCB 209 were used to correct results,
TBB recoveries were 74.5–99%, and PCB 209 82.6–98%.
Limits of detection (LOD) and quantification (LOQ) were
calculated from blanks (LOD = mean of all blanks plus three
times the standard deviation, LOQ = mean plus five times the
standard deviation), or if the compound was absent from the
blanks, from instrument limits of detection using injections
of dilutions of standards (table 1). This method performed
satisfactorily in repeated international intercalibration exer-
cises within the Arctic Monitoring and Assessment
Programme (AMAP 2004).10
All the analyses were carried out in the Department of
Environmental Chemistry (CID-CSIC). We present results for
the most prevalent compounds found in meconium samples:
HCB, p,p9-DDE, p,p9-DDT, b-HCH, and PCBs (congeners 28,
118, 138, 153, 180). Levels of OCs in meconium were adjusted
for total organic carbon (TOC).
Statistical analysis
Initial descriptive statistical parameters were computed.
Pearson’s r, Kendall’s tau, and Spearman’s (rs) correlation
coefficient, and simple linear regression analysis were
conducted to model the adjusted association between levels
of OCs in cord blood and meconium. The criterion of
statistical significance was p , 0.01.
RESULTS
We analysed 10 cord blood samples and 30 meconium
samples. The mean age of the mothers was 29.6 years,
gestational age 39.7 weeks, and weight of newborns 3352 g.
All deliveries were spontaneous and with non-meconial
amniotic fluid. Apgar of all newborns was 9/10 (score at 1
and 5 minutes). Levels of p,p9-DDE in cord blood were
detected and quantifiable in 100% of the samples, and levels
of b-HCH, PCBs, DDT, and HCB in 50%, 50%, 20%, and 0%,
respectively. Levels of p,p9-DDE in meconium were detected
and quantifiable in 100% of the samples, and levels of
b-HCH, PCBs, DDT, and HCB in 90%, 90%, 80%, and 80%,
respectively. Table 2 shows the detected levels of organo-
chlorine in meconium and cord blood. We normalised them
by dividing the results in meconium by the quantity of total
organic carbon (TOC) (g/ml) present in meconium. Thus, the
concentration differences show that different levels of
pollutants have reached the fetus throughout gestation.
Figure 1 shows, from serial stool sample collection in
newborns, an increase of the concentrations of OCs from
the first stool of the newborn to the last one. We observed an
Table 2 HCB, p,p9-DDE, p,p9-DDT, PCBs, and b-HCH levels in cord blood serum and meconium
Cord blood serum (ng/ml)
n = 10
Meconium (ng/g)
n = 30 Meconium/TOC (ng/ml)
Mean SD (range) Mean SD (range) Mean
HCB 0.00 0.000 (0.00–0.00) 1.39 1.30 (0.00–4.18) 0.028
b-HCH 0.07 0.083 (0.00–0.21) 0.40 0.36 (0.00–1.02) 0.008
PCB 28 0.00 0.000 (0.00–0.00) 0.06 0.08 (0.00–0.21) 0.001
pp9DDE 0.31 0.221 (0.08–0.73) 7.19 7.00 (0.61–38.66) 0.140
PCB 118 0.00 0.013 (0.00–0.04) 0.05 0.10 (0.00–0.51) 0.001
PCB 153 0.01 0.029 (0.00–0.092) 0.72 0.72 (0.00–1.48) 0.013
pp9DDT 0.01 0.027 (0.00–0.07) 0.18 0.49 (0.00–1.57) 0.003
PCB 138 0.01 0.024 (0.00–0.07) 0.44 0.47 (0.07–1.41) 0.008
PCB 180 0.00 0.000 (0.00–0.00) 0.38 0.38 (0.00–1.04) 0.006
0.4000
0.3500
0.3000
0.2500
0.2000
0.1500
0.1000
0.0500
0.0000
0.800
Meconium/TOC (ng/ml)
y = 0.5227x – 0.0291
R2 = 0.78 (p < 0.001)
pp-DDE
C
or
d 
bl
oo
d 
(n
g/
m
l)
0.000 0.6000.4000.200
Figure 2 Cord blood and meconium/TOC regression analyses.
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increase of the concentrations of the HCB (Kendall’s
t= 0.583, p , 0.04), p,p9-DDE (Kendall’s t= 0.714,
p , 0.03), PCBs (Kendall’s t= 0.760, p , 0.03), and
b-HCH (Kendall’s t= 0.573, p , 0.05) from the first stool
of the newborn to the last one.
The associations between the organochlorinated com-
pounds in cord blood and meconium were derived from
simple linear regression analysis. The concentrations of p,p9-
DDE and b-HCH in meconium were highly correlated with
the concentrations in cord blood. Positive Pearson (r) and
Spearman (rs) correlation coefficients were observed in p,p9-
DDE (r = 0.883, p , 0.001 and rs = 0.952, p , 0.001) and
b-HCH (r = 0.858, p , 0.001 and rs = 0.821, p , 0.01) (figs 2
and 3). Total PCBs presented a moderate correlation
(r = 0.792, p , 0.01 and rs = 0.623, p , 0.054).
DISCUSSION
Traditionally, efforts to determine fetal exposure to neuro-
toxicants have focused on neonatal or maternal urine or cord
blood analysis, but these samples reflect exposure to these
agents only in the 2–3 days before delivery. Neonatal urine is
difficult to collect, and cord blood is only available at the
precise point of childbirth, making difficult and expensive to
collect. We have observed that meconium analysis is useful
for detecting fetal exposure to a number of neurotoxic agents
that are deposited during pregnancy as early as the 12th
week. Neurotoxicants and their metabolites may enter
meconium via various pathways: (1) diffusion from blood
borne chemicals; (2) swallowing those substances excreted
by the skin and kidney, and fetal defecation into the amniotic
liquid; and (3) excretion into the intestinal tract through the
bile after hepatic metabolism or other intestinal secretions.
Different studies suggest that once the toxic substances or
metabolites reach the meconium, they remain ‘‘fossilised’’.11–14
In the meconium there may be many chemical substances
with potential neurotoxic properties: pesticides, metals,
PCBs, and drugs.
The collection of meconium is easy, and cumulative
samples may be collected over several days. From one sample
multiple chemical substances can be analysed. Our pre-
liminary study indicates that with a very small quantity of
biological material, as little as 1 gram, we are able to detect
exposure to several substances. It should be noted that with
meconium, quantities weighing several grams can be
obtained (up to 100 g in many cases), whereas with cord
blood, as little as 1 ml is usually available. Meconium can
therefore be very useful in detecting substances of prenatal
exposure in comparison with other types of sample.15–19
Many questions remain to be answered about the deposi-
tion of neurotoxicants in meconium. Quantitative and
qualitative differences in the OCs detected were observed in
the different stools.
Could the presence of a particular analyte be a marker for
neurotoxicant exposure at a certain gestational age?
Meconium is not a homogeneous specimen, but a series of
layers formed in the intestine during gestation. Most
analytical methods advise a thorough mixing of the specimen
before analysis because the distribution of neurotoxicants
throughout a sample may not be uniform. Serial analyses of
meconium could help to determine the degree and the timing
of the exposure. We have used the suggestions of previous
studies carried out by Ostrea et al, who proposed that
meconium taken between 0 and 10 hours of life reflects the
first 20 weeks of exposure, between 11 and 20 hours
corresponds to 30 weeks of exposure, and between 21 and
36 hours corresponds to a gestational age greater than
30 weeks.20 Although the sample size is small, an increase
of the transplacental step is observed throughout pregnancy
in most of the analysed substances. The increase in the fetal-
placental blood circulation system could explain the increase
in the concentration of metabolites throughout pregnancy.
New data about the presence of DDT in meconium show how
concentration levels decrease throughout pregnancy. These
results could indicate a mechanism of fetal specific hydro-
lysis, characteristic only in the fetal period. Analysis and
interpretation of results in meconium is a complex process,
and over-interpretation of meconium data is a dangerous
practice, especially at the current developmental stage of this
new and useful technology.
There are some limitations in this study due to the small
size of the population. An arbitrary decision was made to
limit the analysis of meconium samples; this decision was
taken in view of the fact that this study was an exploratory
investigation.
We conclude that the analysis of meconium allows
detection of prenatal exposure to environmental toxins,
specifically neurotoxicants. For the accumulation of toxins
it could be a good indicator of time of exposure and fetal
internal dose or total fetal burden. We propose that this
method constitutes an important tool for investigation of
exposure to environmental pollutants of pregnant women
and their potential adverse effects on infants in the study
of the INMA cohort (Infancia y Medioambiente).21 Such
data will help to determine whether routine meconium
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Figure 3 Cord blood and meconium/TOC regression analyses.
What is already known on this topic
N The fetal period probably constitutes the most impor-
tant critical window of exposure for children’s health
N The critical periods of brain development are especially
vulnerable to numerous transplacental chemical neuro-
toxicants
What this study adds
N Due to its physiological characteristics, meconium
could be a new and sensitive tool for studying the
exposure timing to chemical neurotoxicants
N Knowledge of exposure timing could help to minimise
and prevent short and long term adverse effects
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assessment will help clinical practice by showing harmful
exposures and encouraging the use of appropriate preventive
measures.
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